Department of Voice, Speech and Hearing Disorders, University Dysphagia Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Medical Psychology, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Neuromuscul Dis. 2024;11(2):473-483. doi: 10.3233/JND-230177.
The manifestation of bulbar symptoms, especially swallowing, is important for evaluating disease-modifying therapies for spinal muscular atrophy (SMA). Due to the lack of instruments, the topic is still underrepresented in research.
This study aimed to develop a tool to monitor swallowing development in children aged 0 to 24 months with SMA.
The method was guided by the COSMIN guidelines and followed a multi-stage Delphi process. The first step was a rapid review of swallowing outcomes in children with SMA younger than 24 months. In the second step, online group interviews with experts (n = 7) on dysphagia in infants were conducted, followed by an anonymous online survey among experts in infants with SMA (n = 19). A predefined consensus threshold for nominal scaled voting was set at≥75 % and for 5-point Likert scale voting at 1.25 of the interquartile range. The third step was the pilot test of the instrument, performed with three groups (healthy controls n = 8; pre-symptomatic n = 6, symptomatic n = 6).
Based on the multi-level interprofessional consensus, the DySMA comprises two parts (history and examination), ten categories, with 36 items. Implementation and scoring are clearly articulated and easy to implement. The pilot test showed that swallowing development could be recorded in all groups.
The DySMA is well suited for monitoring swallowing development in pre-symptomatic and symptomatic treated infants with SMA. It can be performed in a time-efficient and interprofessional manner. The resulting score is comparable to results from other instruments measuring other domains, e.g., motor function.
球部症状(尤其是吞咽)的表现对于评估脊髓性肌萎缩症(SMA)的疾病修饰疗法非常重要。由于缺乏仪器,该主题在研究中仍然代表性不足。
本研究旨在开发一种工具,以监测 0 至 24 个月大的 SMA 患儿的吞咽发育情况。
该方法以 COSMIN 指南为指导,并遵循多阶段 Delphi 流程。第一步是对 24 个月以下 SMA 患儿的吞咽结局进行快速综述。第二步,对婴儿吞咽障碍的专家(n=7)进行在线小组访谈,随后对 SMA 婴儿的专家进行匿名在线调查(n=19)。名义量表投票的共识阈值预设为≥75%,5 点 Likert 量表投票为四分位距的 1.25。第三步是对该仪器进行预试验,分为三组进行(健康对照组 n=8;无症状前组 n=6,有症状组 n=6)。
基于多层次跨专业共识,DySMA 包括两部分(病史和检查),十个类别,共 36 个项目。实施和评分清晰明确,易于实施。预试验表明,所有组均可记录吞咽发育情况。
DySMA 非常适合监测 SMA 无症状前和有症状治疗婴儿的吞咽发育情况。它可以以高效和跨专业的方式进行。所得评分可与其他测量其他领域(如运动功能)的仪器的结果相媲美。